Glucose is the energy currency essential for physiological processes in the living cells. It serves as a precursor for glycoproteins, glycolipids and glycosaminoglycans. Glucose solution is a commonly used feed in the biopharmaceutical industry. Applying High Temperature Short Time (HTST) technology to 50% Glucose inactivates any adventitious viral agents that may be present thereby forming part of an overall virus risk mitigation strategy in your upstream process. HTST treated Glucose offers the same feed viability and performance as non-HTST treated Glucose however has the additional benefit of HTST pasteurization in addition to sterile filtration.
Features:- Viral Inactivation-HTST pasteurization involves rapid heating to over 100°C for a specified time, achieving greater than 6 log inactivation of viruses such as the Minute Virus of Mice (MVM), ensuring a robust viral safety profile.
- Sterility and Quality- The glucose solution is sterile-filtered, endotoxin-tested, and free of animal components, maintaining high standards of purity and safety for biopharmaceutical applications.
- Convenience and Packaging - It is available in a ready-to-use liquid form, shipped in single-use bags that have undergone rigorous ISTA ship testing, ensuring ease of use and reliable delivery.
- Scalability- Suitable for both clinical and commercial scale operations, the HTST treated glucose supports flexible scalability in bioprocessing applications, making it an integral part of viral risk mitigation strategies in cell culture media feeds.